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Introduction
Periodic fever, aphthous stomatitis, pharyngitis, and ade-
nopathy (PFAPA) syndrome is a clinical entity of
unknown etiology, characterized by periodic attacks of
fever, associated with aphthous stomatitis, pharyngitis
and cervical adenopathy.
Objectives
The aim of this study was to evaluate the demographic,
clinical, laboratory and genetic characteristics of PFAPA
patients, and to compare the parameters between MEFV
carriers and noncarriers.
Methods
Seventy-one children were enrolled in the study diag-
nosed as PFAPA according to the previously published
criteria and followed-up at the Pediatric Rheumatology
Clinic of Hacettepe Children’s Hospital. Mutation analy-
sis included MEFV gene mutations. The ethical commit-
tee of our institute approved the study protocol.
Results
The median age of onset was 12 months, with a male-
to-female ratio of 1,6:1. The length of fever attacks ran-
ged between 2-8 days, and symptom-free intervals
between 10-45 days. The most common associated
symptoms were pharyngitis (100%), abdominal pain
(45,1%), aphthous stomatitis (43,7%), and cervical lym-
phadenitis (32,4%). During fever flares, the leukocyte
count and acute phase reactants (ESR and CRP) were
significantly higher (p<0,001). Of 53 patients tested for
MEFV mutations, 2 were homozygote, while 20 had a
single MEFV mutation (9 of them with M694V muta-
tion). Thus carrier frequency reached 1:2,6, higher than
the overall carrier frequency in healthy Turkish popula-
tion which is 1:5 (p=0,037). Also, nearly half of these
patients had a M694V mutation (associated with higher
clinical severity in FMF) which is around 15% in healthy
Turkish carriers. No differences were found between
carriers and noncarriers in demographic data, clinical
and laboratory parameters and response to therapies.
In 37 of the 38 who received steroids, attacks were
abrupted. The attacks recurred in only 1 out of 10
patients who underwent tonsillectomy. We have also
shown a positive family history of recurrent pharyngitis
in 52,1% of patients.
Conclusion
The MEFV carrier frequency and M694V was signifi-
cantly higher as compared to the healthy population.
The high family history supports the heritability in
PFAPA pathogenesis. PFAPA is a polygenic disease; the
association with MEFV mutations in certain ethnic
groups may suggest their possible role through the
innate immune system. Studying the role of inflamma-
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